Log In
    News

    Channelchek Takeaway Series – Reuters Global Energy Transition

    6/23/2023
    Energy
    0 min read

    Takeaways from the Reuters Global Energy Transition Event

    All videos now live on demand!

    The Takeaway Series is available exclusively to Channelchek members. It’s totally free to join the community, just click the join button at the top of the page, or the Register button below.For best results, log in to your Channelchek account above before viewing the videos.

    Join Channelchek

    Watch the Entire Event

    Noble Capital Markets Senior Research Analyst Michael Heim provides his takeaways from the event, plus all the fireside chats with c-suite energy executives. All in one click.

    Watch the Video

    ———-

    Watch the Individual Presentations

    ———-

    Analyst Takeaways

    Noble Capital Markets Senior Research Analyst Michael Heim provides his takeaways from the event.

    Watch the Video

    ———-

    Alvopetro Energy (ALVOF)

    Corey C. Ruttan, President & CEO

    Watch the Video

    ———-

    InPlay Oil Corp. (IPOOF)

    Douglas J. Bartole, President & CEO

    Watch the Video

    ———-

    Energy Fuels Inc. (UUUU)

    Mark S. Chalmers, President & CEO

    Watch the Video

    ———-

    Expion360 Inc. (XPON)

    Brian Schaffner, CEO
    Paul Shoun, Co-Founder, President, COO, Director

    Watch the Video

    Share
    Related News
    ‌
    Conduent Inc. (CNDT) – Lowering Forecast, Business Transformation Plan Still on Track
    11/15/2024
    Technology

    Conduent Inc. (CNDT) – Lowering Forecast, Business Transformation Plan Still on Track

    Q3 in line. The company reported a Q3 revenue of $807 million, largely in line with our estimate of $814 million. Adj. EBITDA was $36 million, better than our estimate...
    2 min read
    ‌
    ZyVersa Therapeutics, Inc. (ZVSA) – Reported 3Q24 With Clinical Trials Beginning In 2025
    11/15/2024
    Health

    ZyVersa Therapeutics, Inc. (ZVSA) – Reported 3Q24 With Clinical Trials Beginning In 2025

    3Q24 Reported With Product Updates. ZyVersa reported a loss of $2.4 million or $(2.43) per share and updated its clinical trial plans for the two products in development. During the quarter,...
    2 min read
    ‌
    PDS Biotechnology (PDSB) – 3Q24 Reported With Phase 3 VERSATILE-003 Trial Expected To Begin In 1Q25
    11/15/2024
    Health

    PDS Biotechnology (PDSB) – 3Q24 Reported With Phase 3 VERSATILE-003 Trial Expected To Begin In 1Q25

    Progress Toward Phase 3 With New Phase 2 VERSATILE-002 Data. PDS Biotech Reported 3Q24 loss of $10.7 million or $(0.29) per share, a slightly lower loss than we estimated. Earlier this week,...
    3 min read
    ‌
    Lifeway Foods (LWAY) – Year-over-Year Growth, But Below Our Expectations
    11/15/2024
    Consumer

    Lifeway Foods (LWAY) – Year-over-Year Growth, But Below Our Expectations

    Another Quarter of Y-o-Y Growth. For the 20th consecutive quarter, Lifeway reported y-o-y top line growth. Revenue for the quarter totaled $46.1 million, compared to the prior year’s $40.9 million, We were...
    2 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In